Press-release for stocks related to cancer for nvs

tags : Cancer symbols : Nvs

save search

Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
NVS | News | $97.515 0.24% 820K

Health Technology

| 4.54% | O: 0.32% H: 0.04% C: -0.56%
ARVN | $33.26 -2.18% 69K

Health Technology

| -5.9% | O: 8.28% H: 0.56% C: -4.75%
arv-766 protac license cancer treatment global protein for commercialization agreement

Radiopharmaceuticals Market to Reach $11.6 Billion by 2034 as Cancer Treatment Gains Traction - Future Market Insights, Inc.
Published: 2024-03-25 (Crawled : 15:00) - prnewswire.com
NVSEF | News | $96.0 52K

Health Technology

| -0.4% | O: -100.0% H: NaN% C: Infinity%
NVS | News | $97.515 0.24% 820K

Health Technology

| 2.73% | O: -0.08% H: 0.15% C: -0.44%
LLY | News | $731.46 -1.91% 700K

Health Technology

| -4.1% | O: 0.06% H: 0.96% C: 0.26%
CAH | $103.26 -0.11% 260K

Distribution Services

| -7.7% | O: 0.02% H: 0.73% C: -0.02%
LNTH | $64.205 -0.32% 110K

Health Technology

| 9.13% | O: 0.1% H: 1.98% C: -0.08%
reach cancer treatment market

Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published: 2024-02-22 (Crawled : 01:00) - prnewswire.com
GLAXF | News | $19.54 2.6K

Health Technology

| -8.95% | O: 0.14% H: 0.0% C: -0.0%
SNYNF | News | $94.25 480

Health Technology

| -1.52% | O: 0.26% H: 1.36% C: 1.36%
AZNCF | News | $140.3 1.5K

Health Technology

| 10.47% | O: -0.85% H: 1.12% C: 0.43%
NVSEF | News | $96.0 52K

Health Technology

| -5.82% | O: 0.92% H: 0.0% C: 0.0%
UCBJY | $65.26 5.9K

Manufacturing

| 28.21% | O: 1.46% H: 0.44% C: 0.44%
ALPMY | News | $9.49 480K

Manufacturing

| -14.66% | O: -0.27% H: 0.0% C: -1.17%
TAK | News | $13.23 -1.12% 300K

Health Technology

| -9.46% | O: -0.2% H: 0.14% C: -0.48%
NVS | News | $97.515 0.24% 820K

Health Technology

| -3.61% | O: -0.06% H: 0.46% C: 0.29%
GSK | News | $40.73 -1.24% 360K

Health Technology

| -1.67% | O: -0.69% H: 1.42% C: 1.22%
LLY | News | $731.46 -1.91% 700K

Health Technology

| -0.92% | O: 2.37% H: 1.51% C: 0.79%
BMY | $48.64 -0.71% 2.3M

Health Technology

| -3.77% | O: -0.65% H: 1.63% C: 1.48%
ABBV | News | $168.1 -0.85% 670K

Health Technology

| -3.85% | O: -0.88% H: 1.46% C: 1.13%
SNY | News | $46.82 -1.82% 510K

Health Technology

| -0.15% | O: 1.67% H: 0.0% C: 0.0%
AZN | News | $70.93 0.11% 2.3M

Health Technology

| 8.85% | O: -2.81% H: 2.08% C: 1.38%
AMGN | News | $273.6 0.02% 370K

Health Technology

| -3.5% | O: -0.35% H: 1.15% C: 0.96%
lung reach cancer cell diagnostics therapy market

9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published: 2024-02-19 (Crawled : 16:00) - prnewswire.com
BIIB | $202.05 4.59% 1.1M

Health Technology

| Email alert Add to watchlist
VTRS | News A | $11.34 -0.18% 900K

Health Technology

| Email alert Add to watchlist
NVSEF | News | $96.0 52K

Health Technology

| Email alert Add to watchlist
AZN | News | $70.93 0.11% 2.3M

Health Technology

| Email alert Add to watchlist
GLAXF | News | $19.54 2.6K

Health Technology

| Email alert Add to watchlist
GSK | News | $40.73 -1.24% 360K

Health Technology

| Email alert Add to watchlist
AZNCF | News | $140.3 1.5K

Health Technology

| Email alert Add to watchlist
JAZZ | $108.03 -1.5% 89K

Health Technology

| Email alert Add to watchlist
NVS | News | $97.515 0.24% 820K

Health Technology

| Email alert Add to watchlist
AMGN | News | $273.6 0.02% 370K

Health Technology

| Email alert Add to watchlist
cancer cell global growth market

Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published: 2024-02-06 (Crawled : 00:00) - prnewswire.com
ALPMF | News | $9.5 1.2K

Health Technology

| -14.57% | O: -1.53% H: 0.0% C: 0.0%
AZNCF | News | $140.3 1.5K

Health Technology

| 4.83% | O: -0.37% H: 0.0% C: 0.0%
NVSEF | News | $96.0 52K

Health Technology

| -6.68% | O: 0.41% H: 0.0% C: 0.0%
UCBJY | $65.26 5.9K

Manufacturing

| 39.56% | O: 1.71% H: 1.28% C: 0.94%
ALPMY | News | $9.49 480K

Manufacturing

| -12.86% | O: 0.28% H: 0.18% C: 0.0%
TAK | News | $13.23 -1.12% 300K

Health Technology

| -5.76% | O: 0.07% H: 0.42% C: 0.07%
NVS | News | $97.515 0.24% 820K

Health Technology

| -4.7% | O: 0.09% H: 0.39% C: -0.36%
JNJ | News | $147.27 -1.53% 2.3M

Health Technology

| -3.9% | O: 1.47% H: 0.0% C: 0.0%
LLY | News | $731.46 -1.91% 700K

Health Technology

| 4.83% | O: 0.76% H: 4.31% C: 2.11%
BMY | $48.64 -0.71% 2.3M

Health Technology

| -0.55% | O: -0.14% H: 0.35% C: -1.12%
ABBV | News | $168.1 -0.85% 670K

Health Technology

| -0.87% | O: 1.48% H: 0.0% C: 0.0%
VRTX | $401.125 -0.94% 190K

Health Technology

| -2.7% | O: 0.15% H: 2.4% C: 0.56%
SNY | News | $46.82 -1.82% 510K

Health Technology

| 1.14% | O: 1.33% H: 0.0% C: 0.0%
JAZZ | $108.03 -1.5% 89K

Health Technology

| -12.06% | O: -0.02% H: 0.0% C: -1.4%
AZN | News | $70.93 0.11% 2.3M

Health Technology

| 5.68% | O: -0.4% H: 0.19% C: -0.33%
AMGN | News | $273.6 0.02% 370K

Health Technology

| -13.46% | O: -0.18% H: 0.0% C: -6.22%
report cancer blood growth market

United States Endometrial Cancer Research Report 2023
Published: 2024-02-02 (Crawled : 10:00) - prnewswire.com
TAK | News | $13.23 -1.12% 300K

Health Technology

| -7.2% | O: 0.21% H: 0.49% C: -0.9%
NVS | News | $97.515 0.24% 820K

Health Technology

| -6.14% | O: -0.5% H: 0.26% C: -1.03%
report cancer research

Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published: 2024-01-30 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $19.54 2.6K

Health Technology

| 1.27% | O: 5.68% H: 0.77% C: 0.77%
AZNCF | News | $140.3 1.5K

Health Technology

| 6.9% | O: 3.41% H: 0.0% C: -2.45%
VTRS | News A | $11.34 -0.18% 900K

Health Technology

| -3.81% | O: -0.08% H: 3.47% C: -0.25%
NVS | News | $97.515 0.24% 820K

Health Technology

| -8.25% | O: -2.04% H: 0.19% C: -1.97%
GSK | News | $40.73 -1.24% 360K

Health Technology

| 5.5% | O: 4.04% H: 1.57% C: -3.02%
ABBV | News | $168.1 -0.85% 670K

Health Technology

| 2.8% | O: 0.5% H: 0.07% C: -0.81%
SNY | News | $46.82 -1.82% 510K

Health Technology

| -6.39% | O: 1.75% H: 0.0% C: 0.0%
PBYI | $4.94 -3.7% 74K

Health Technology

| 7.66% | O: -0.1% H: 2.31% C: -1.26%
AZN | News | $70.93 0.11% 2.3M

Health Technology

| 5.43% | O: 0.82% H: 0.12% C: -1.64%
AMGN | News | $273.6 0.02% 370K

Health Technology

| -13.06% | O: 0.44% H: 0.2% C: -0.55%
drug breast expected cancer pipeline therapeutics growth market

Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published: 2024-01-09 (Crawled : 03:00) - prnewswire.com
ALPMF | News | $9.5 1.2K

Health Technology

| -23.14% | O: 0.16% H: 0.0% C: -3.88%
NVSEF | News | $96.0 52K

Health Technology

| -9.65% | O: -0.24% H: 0.0% C: 0.0%
ALPMY | News | $9.49 480K

Manufacturing

| -22.72% | O: -1.22% H: 0.0% C: -0.72%
NVS | News | $97.515 0.24% 820K

Health Technology

| -7.68% | O: -0.46% H: 0.74% C: -0.19%
SNY | News | $46.82 -1.82% 510K

Health Technology

| -8.67% | O: 0.74% H: 0.0% C: 0.0%
AMGN | News | $273.6 0.02% 370K

Health Technology

| -12.01% | O: -0.92% H: 0.63% C: -0.25%
america cancer treatment market

Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published: 2024-01-04 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 2.6K

Health Technology

| 0.1% | O: 2.46% H: 0.0% C: 0.0%
SNYNF | News | $94.25 480

Health Technology

| -7.46% | O: 0.49% H: 0.6% C: -0.83%
AZNCF | News | $140.3 1.5K

Health Technology

| 2.37% | O: 0.15% H: 1.88% C: -1.17%
NVSEF | News | $96.0 52K

Health Technology

| -8.57% | O: -0.24% H: 1.43% C: 1.43%
NVS | News | $97.515 0.24% 820K

Health Technology

| -6.36% | O: 0.32% H: 0.93% C: 0.38%
GSK | News | $40.73 -1.24% 360K

Health Technology

| 5.55% | O: -0.36% H: 0.98% C: 0.72%
SNY | News | $46.82 -1.82% 510K

Health Technology

| -7.74% | O: -0.14% H: 0.0% C: 0.0%
AZN | News | $70.93 0.11% 2.3M

Health Technology

| 3.01% | O: -0.68% H: 0.87% C: 0.1%
AMGN | News | $273.6 0.02% 370K

Health Technology

| -9.77% | O: -0.32% H: 0.44% C: 0.26%
america cancer immunotherapy market

Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published: 2023-12-14 (Crawled : 01:00) - prnewswire.com
NVS | News | $97.515 0.24% 820K

Health Technology

| -0.85% | O: -1.67% H: 1.17% C: 0.85%
JNJ | News | $147.27 -1.53% 2.3M

Health Technology

| -2.66% | O: 1.81% H: 0.0% C: 0.0%
BMY | $48.64 -0.71% 2.3M

Health Technology

| -5.53% | O: 1.16% H: 0.14% C: -1.89%
AMGN | News | $273.6 0.02% 370K

Health Technology

| -2.87% | O: -0.11% H: 0.5% C: -1.78%
cancer global immunotherapy market

US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 52K

Health Technology

| 0.0% | O: 1.56% H: 0.51% C: 0.51%
NVS | News | $97.515 0.24% 820K

Health Technology

| 1.62% | O: 0.45% H: 0.75% C: 0.46%
AMGN | News | $273.6 0.02% 370K

Health Technology

| 0.51% | O: 1.83% H: 0.04% C: -1.13%
kidney cancer novartis diagnostics therapeutics market

Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published: 2023-12-05 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $19.54 2.6K

Health Technology

| 10.33% | O: 1.64% H: 0.0% C: -1.33%
AZNCF | News | $140.3 1.5K

Health Technology

| 11.57% | O: 1.51% H: 0.13% C: -1.68%
NVS | News | $97.515 0.24% 820K

Health Technology

| 1.95% | O: 0.52% H: 0.18% C: -0.43%
GSK | News | $40.73 -1.24% 360K

Health Technology

| 13.52% | O: -0.03% H: 0.28% C: -0.41%
BAX | $40.705 -0.77% 280K

Health Technology

| 14.58% | O: 0.14% H: 0.78% C: 0.22%
ABBV | News | $168.1 -0.85% 670K

Health Technology

| 17.27% | O: 0.26% H: 0.0% C: 0.0%
AZN | News | $70.93 0.11% 2.3M

Health Technology

| 10.69% | O: 0.73% H: 0.06% C: -1.38%
AMGN | News | $273.6 0.02% 370K

Health Technology

| 0.99% | O: 0.2% H: 0.2% C: -0.76%
GOOGL | News S | $158.12 -0.09% 6.4M

Technology Services

| 21.73% | O: 1.97% H: 0.0% C: 0.0%
GOOG | News 4 | $159.845 -0.05% 5.4M

Technology Services

| 21.65% | O: 1.97% H: 0.0% C: 0.0%
ADBE A | $474.24 0.28% 550K

Technology Services

| -21.47% | O: 0.97% H: 0.08% C: -2.03%
tube companies abbvie cancer pharmaceuticals therapeutics market

Novartis Pluvicto™ shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer in the pre-taxane setting
Published: 2023-10-23 (Crawled : 14:30) - globenewswire.com
NVS | News | $97.515 0.24% 820K

Health Technology

| 4.41% | O: -0.17% H: 0.56% C: 0.18%
cancer novartis

Novartis Kisqali® NATALEE analysis reinforces consistent reduction in risk of recurrence across key subgroups of patients with early breast cancer
Published: 2023-10-20 (Crawled : 10:00) - globenewswire.com
PFE | News 4 | $26.185 -0.51% 6.6M

Health Technology

| -15.61% | O: -0.42% H: 0.16% C: -1.32%
NVS | News | $97.515 0.24% 820K

Health Technology

| 4.46% | O: 0.6% H: 0.61% C: -0.56%
kisqali breast cancer risk novartis

North America Leads the Global Peptide Drug Conjugates Market Due to Increased Cancer Incidence
Published: 2023-10-20 (Crawled : 01:00) - prnewswire.com
NVS | News | $97.515 0.24% 820K

Health Technology

| 4.46% | O: 0.6% H: 0.61% C: -0.56%
america drug cancer global market

Global Next Generation Cancer Diagnostics Market Research Report 2023-2030: Key Players are Focusing on Innovative Product Launches and Geographical Expansion to Maintain their Competitive Edge
Published: 2023-10-06 (Crawled : 09:00) - prnewswire.com
NVSEF | News | $96.0 52K

Health Technology

| -0.93% | O: -0.72% H: 0.0% C: -0.52%
NVS | News | $97.515 0.24% 820K

Health Technology

| 2.82% | O: 0.95% H: 0.41% C: 0.08%
PHG | News | $20.88 -0.62% 210K

Health Technology

| 6.6% | O: -9.44% H: 2.86% C: 2.46%
A | $137.89 -0.94% 220K

Health Technology

| 24.83% | O: -1.81% H: 2.08% C: 1.05%
OPK | $1.235 -1.2% 2M

Health Technology

| -17.22% | O: -1.32% H: 2.68% C: 2.01%
MYGN | $18.48 -0.65% 49K

Health Technology

| 20.08% | O: -0.97% H: 4.4% C: -0.59%
ILMN | $121.115 -2.69% 160K

Health Technology

| -10.74% | O: -1.36% H: 2.95% C: 1.8%
report cancer expansion research global diagnostics market

Novartis to present new oncology data at ESMO 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer
Published: 2023-10-05 (Crawled : 06:00) - globenewswire.com
NVS | News | $97.515 0.24% 820K

Health Technology

| 2.75% | O: -1.21% H: 1.3% C: 1.16%
breast innovation cancer novartis

Sandoz receives positive CHMP opinion for breast and gastric cancer biosimilar trastuzumab
Published: 2023-09-18 (Crawled : 06:00) - globenewswire.com
NVSEF | News | $96.0 52K

Health Technology

| 12.39% | O: -0.05% H: 0.0% C: -1.31%
NVS | News | $97.515 0.24% 820K

Health Technology

| -3.67% | O: 0.06% H: 0.09% C: -0.6%
biosimilar chmp breast positive cancer

Global Next Generation Cancer Diagnostics Market Projected to Reach $57.8 Billion by 2030
Published: 2023-08-18 (Crawled : 00:20) - prnewswire.com
NVSEF | News | $96.0 52K

Health Technology

| Email alert Add to watchlist
NVS | News | $97.515 0.24% 820K

Health Technology

| Email alert Add to watchlist
reach cancer global diagnostics market

Prostate Cancer Global Market to Witness Upsurge in Growth at a CAGR of ~5% by 2028 | DelveInsight
Published: 2023-07-05 (Crawled : 21:00) - prnewswire.com
ALPMY | News | $9.49 480K

Manufacturing

| -33.6% | O: 0.86% H: 0.0% C: -1.01%
NVS | News | $97.515 0.24% 820K

Health Technology

| -0.09% | O: -1.17% H: 0.63% C: 0.22%
LLY | News | $731.46 -1.91% 700K

Health Technology

| 58.7% | O: -0.55% H: 0.97% C: 0.02%
VERU | $1.33 4.31% 600K

Health Technology

| 5.83% | O: -0.83% H: 0.0% C: -6.72%
OPK | $1.235 -1.2% 2M

Health Technology

| -40.48% | O: -1.19% H: 1.2% C: -0.72%
ADXS | $0.54 950

Health Technology

| -43.16% | O: 0.0% H: 0.0% C: -6.83%
cancer global growth market

← Previous
1
2
3
4
5
6
Next →

tags : Cancer symbols : Nvs

save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

tags : Cancer symbols : Nvs save search

Gainers vs Losers

Top 10 Gainers

Your saved searches

tags : Cancer symbols : Nvs

save search